Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer

BackgroundEsophageal cancer often appears as postoperative metastasis or recurrence after radical surgery. Although we had previously reported that serum programmed cell death ligand 1 (PD-L1) level correlated with the prognosis of esophageal cancer, further novel biomarkers are required for more pr...

Full description

Bibliographic Details
Main Authors: Masaaki Ito, Takaki Hiwasa, Yoko Oshima, Satoshi Yajima, Takashi Suzuki, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Kimihiko Funahashi, Shu-Yang Li, Yasuo Iwadate, Hiroki Yamagata, Byambasteren Jambaljav, Minoru Takemoto, Koutaro Yokote, Hirotaka Takizawa, Hideaki Shimada
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
proprotein convertase subtilisin/kexin type 9
programmed cell death ligand 1
esophageal cancer
antibody biomarker
overall survival
hyperlipidemia
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.708039/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.708039/full

Similar Items